Octagon Capital Advisors’s OnKure Therapeutics, Inc. Class A Common Stock OKUR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-225,000
| Closed | -$3.83M | – | 47 |
|
|
2024
Q3 | $3.83M | Hold |
225,000
| – | – | 0.6% | 28 |
|
|
2024
Q2 | $3.4M | Hold |
225,000
| – | – | 0.53% | 31 |
|
|
2024
Q1 | $3.74M | Hold |
225,000
| – | – | 0.45% | 41 |
|
|
2023
Q4 | $3.6M | Sell |
225,000
-2,987
| -1% | -$47.8K | 0.58% | 24 |
|
|
2023
Q3 | $17.4M | Sell |
227,987
-8,872
| -4% | -$676K | 2.67% | 11 |
|
|
2023
Q2 | $15.5M | Buy |
236,859
+194,859
| +464% | +$12.8M | 2.16% | 13 |
|
|
2023
Q1 | $2.51M | Buy |
+42,000
| New | +$2.51M | 0.36% | 29 |
|